PMID- 18055523 OWN - NLM STAT- MEDLINE DCOM- 20080331 LR - 20200930 IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 294 IP - 2 DP - 2008 Feb TI - Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. PG - H750-63 AB - Intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) play critical roles in mediating monocyte adhesion to the vascular endothelium and monocyte migration into the subendothelial regions of the vessels. Inasmuch as cardiotrophin-1 (CT-1), an IL-6-type cytokine, was expressed in human atherosclerotic plaque, we examined whether CT-1 induces monocyte adhesion and migration by stimulating gene and protein expressions of ICAM-1 and MCP-1 in human aortic endothelial cells (HAECs). Immunocytochemistry revealed that CT-1 increased intensity of ICAM-1 and MCP-1 immunoreactivity in HAECs. Adhesion assay and chemotaxis assay revealed that CT-1 increased human monocytic THP-1 cell adhesion to HAECs and promoted chemotaxis in THP-1 cells, which were attenuated by anti-ICAM-1 and anti-MCP-1 antibody, respectively. Western blot analysis showed that CT-1 increased phosphorylation of ERK1/2 MAP kinase, p38 MAP kinase, and Akt and that their inhibitors, PD-98059, SB-203580, and LY-294002, respectively, inhibited phosphorylation. RNase protection assay and ELISA demonstrated that CT-1 increased gene and protein expressions of ICAM-1 and MCP-1. EMSA revealed that CT-1 enhanced NF-kappaB DNA-binding activity. CT-1-mediated upregulation of ICAM-1 and MCP-1 was suppressed by PD-98059, SB-203580, LY-294002, and parthenolide. The present study demonstrates that CT-1 promotes monocyte adhesion and migration by stimulating ICAM-1 and MCP-1 through mechanisms that involve ERK1/2 MAP kinase, p38 MAP kinase, phosphatidylinositol 3-kinase, and NF-kappaB pathways and suggests that CT-1 plays an important role in the pathophysiology of vascular inflammation and atherosclerosis. FAU - Ichiki, Tomoko AU - Ichiki T AD - Institute for Clinical Research, National Hospital Organization Kagoshima Medical Center, 8-1 Shiroyama-cho, Kagoshima 892-0853, Japan. FAU - Jougasaki, Michihisa AU - Jougasaki M FAU - Setoguchi, Manabu AU - Setoguchi M FAU - Imamura, Junichi AU - Imamura J FAU - Nakashima, Hitoshi AU - Nakashima H FAU - Matsuoka, Tatsuru AU - Matsuoka T FAU - Sonoda, Masahiro AU - Sonoda M FAU - Nakamura, Kazuhiko AU - Nakamura K FAU - Minagoe, Shinichi AU - Minagoe S FAU - Tei, Chuwa AU - Tei C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20071130 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Enzyme Inhibitors) RN - 0 (Indicators and Reagents) RN - 0 (LIFR protein, human) RN - 0 (Leukemia Inhibitory Factor Receptor alpha Subunit) RN - 0 (NF-kappa B) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - 133483-10-0 (Cytokine Receptor gp130) RN - 63231-63-0 (RNA) RN - AJ7U77BR8I (cardiotrophin 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Aged MH - Atherosclerosis/pathology MH - Blotting, Western MH - Cell Adhesion/drug effects MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis MH - Chemotaxis/drug effects MH - Cytokine Receptor gp130/biosynthesis MH - Cytokines/*pharmacology MH - Endothelial Cells/drug effects/*metabolism MH - Enzyme Inhibitors/pharmacology MH - Female MH - Gene Expression/drug effects MH - Humans MH - Immunohistochemistry MH - Indicators and Reagents MH - Intercellular Adhesion Molecule-1/*biosynthesis MH - Leukemia Inhibitory Factor Receptor alpha Subunit/biosynthesis MH - Male MH - Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism MH - NF-kappa B/metabolism MH - Nuclease Protection Assays MH - Phosphorylation MH - RNA/biosynthesis/isolation & purification EDAT- 2007/12/07 09:00 MHDA- 2008/04/01 09:00 CRDT- 2007/12/07 09:00 PHST- 2007/12/07 09:00 [pubmed] PHST- 2008/04/01 09:00 [medline] PHST- 2007/12/07 09:00 [entrez] AID - 00161.2007 [pii] AID - 10.1152/ajpheart.00161.2007 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H750-63. doi: 10.1152/ajpheart.00161.2007. Epub 2007 Nov 30.